Today’s approval means that FluMist is the first pharmacy-prescribed influenza vaccine that does not need to be given by a ...

Respondents predict that the highest rates will be reflected in all outpatient prescription drugs with an 11.4% increase, up ...

The complaint targets the group purchasing organizations affiliated with the "big three" pharmacy benefit managers: CVS ...

Children with spinal muscular atrophy (SMA) experience benefits from receiving a disease-modifying gene therapy, but many ...

Cure” is a not an immutable term, the authors of a new study write, and its meaning depends on the context in which it is ...

Three different doses of Niktimvo all had high rates of response among patients with recurrent or refractory ...

The future of pain medicine is characterized by treatments and technologies — including virtual reality, AI, wearable tech ...

Merck and Johnson & Johnson have both acquired bispecific antibodies with applications in autoimmune and inflammatory conditions. Driving this growth will be the approvals of novel biologics, such as ...

Do you foresee IV and subQ route of administration always having a role moving forward? How do you see the treatment landscape changing?